Table 1.
Author | Accrual | Median Age | Median PSA (ng/mL) at Enrollment | % Achieving PSA Decrease | Time to Progression (Days) | Etoposide included? |
---|---|---|---|---|---|---|
Szmulewitz et al. | 15 | 73 | 11.1 | 20 | 63(14–672) | No etoposide |
Morris et al. | 12 | 65 | 9.1 | 58 | 86 (27–250) | No etoposide |
Schweizer et al. | 14 | 71 | 21.7 | 50 | 221 (95 – 454) | Etoposide included |